These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


332 related items for PubMed ID: 15069621

  • 1. Immunohistochemical analysis of tumor biological factors in hepatocellular carcinoma: relationship to clinicopathological factors and prognosis after hepatic resection.
    Nanashima A, Yano H, Yamaguchi H, Tanaka K, Shibasaki S, Sumida Y, Sawai T, Shindou H, Nakagoe T.
    J Gastroenterol; 2004; 39(2):148-54. PubMed ID: 15069621
    [Abstract] [Full Text] [Related]

  • 2. P21/WAF1 is an independent survival prognostic factor for patients with hepatocellular carcinoma after resection.
    Kao JT, Chuah SK, Huang CC, Chen CL, Wang CC, Hung CH, Chen CH, Wang JH, Lu SN, Lee CM, Changchien CS, Hu TH.
    Liver Int; 2007 Aug; 27(6):772-81. PubMed ID: 17617120
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of macrophage migration inhibitory factor induces angiogenesis and deteriorates prognosis after radical resection for hepatocellular carcinoma.
    Hira E, Ono T, Dhar DK, El-Assal ON, Hishikawa Y, Yamanoi A, Nagasue N.
    Cancer; 2005 Feb 01; 103(3):588-98. PubMed ID: 15612021
    [Abstract] [Full Text] [Related]

  • 4. Longterm prognosis after hepatic resection for small hepatocellular carcinoma.
    Shimozawa N, Hanazaki K.
    J Am Coll Surg; 2004 Mar 01; 198(3):356-65. PubMed ID: 14992736
    [Abstract] [Full Text] [Related]

  • 5. Assessment of the biological malignancy of hepatocellular carcinoma: relationship to clinicopathological factors and prognosis.
    Mise K, Tashiro S, Yogita S, Wada D, Harada M, Fukuda Y, Miyake H, Isikawa M, Izumi K, Sano N.
    Clin Cancer Res; 1998 Jun 01; 4(6):1475-82. PubMed ID: 9626465
    [Abstract] [Full Text] [Related]

  • 6. c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.
    Tomić S, Ilić Forko J, Babić D, Sundov D, Kuret S, Andelinović S.
    Croat Med J; 2003 Aug 01; 44(4):429-34. PubMed ID: 12950146
    [Abstract] [Full Text] [Related]

  • 7. [The expression and significance of heparanase and nm23-H1 in hepatocellular carcinoma].
    Liu Y, Chen X, Peng S, Fang H, Wu Y, Peng C, Shi L, Bai M, Xu B, Wang J, Deng G.
    Zhonghua Yi Xue Za Zhi; 2002 Nov 25; 82(22):1553-6. PubMed ID: 12609066
    [Abstract] [Full Text] [Related]

  • 8. Expression of p53, Bcl-2, VEGF, Ki67 and PCNA and prognostic significance in hepatocellular carcinoma.
    Stroescu C, Dragnea A, Ivanov B, Pechianu C, Herlea V, Sgarbura O, Popescu A, Popescu I.
    J Gastrointestin Liver Dis; 2008 Dec 25; 17(4):411-7. PubMed ID: 19104702
    [Abstract] [Full Text] [Related]

  • 9. Predictors and patterns of recurrence after resection of hepatocellular carcinoma.
    Cha C, Fong Y, Jarnagin WR, Blumgart LH, DeMatteo RP.
    J Am Coll Surg; 2003 Nov 25; 197(5):753-8. PubMed ID: 14585409
    [Abstract] [Full Text] [Related]

  • 10. Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors.
    Sumie S, Kuromatsu R, Okuda K, Ando E, Takata A, Fukushima N, Watanabe Y, Kojiro M, Sata M.
    Ann Surg Oncol; 2008 May 25; 15(5):1375-82. PubMed ID: 18324443
    [Abstract] [Full Text] [Related]

  • 11. Neural cadherin overexpression is a predictive marker for early postoperative recurrence in hepatocellular carcinoma patients.
    Seo DD, Lee HC, Kim HJ, Min HJ, Kim KM, Lim YS, Chung YH, Lee YS, Suh DJ, Yu E, Chun SY.
    J Gastroenterol Hepatol; 2008 Jul 25; 23(7 Pt 1):1112-8. PubMed ID: 17944884
    [Abstract] [Full Text] [Related]

  • 12. Tumor-associated lymphangiogenesis correlates with prognosis after resection of human hepatocellular carcinoma.
    Thelen A, Jonas S, Benckert C, Weichert W, Schott E, Bötcher C, Dietz E, Wiedenmann B, Neuhaus P, Scholz A.
    Ann Surg Oncol; 2009 May 25; 16(5):1222-30. PubMed ID: 19224279
    [Abstract] [Full Text] [Related]

  • 13. Stathmin overexpression cooperates with p53 mutation and osteopontin overexpression, and is associated with tumour progression, early recurrence, and poor prognosis in hepatocellular carcinoma.
    Yuan RH, Jeng YM, Chen HL, Lai PL, Pan HW, Hsieh FJ, Lin CY, Lee PH, Hsu HC.
    J Pathol; 2006 Aug 25; 209(4):549-58. PubMed ID: 16739096
    [Abstract] [Full Text] [Related]

  • 14. Expression of hepatoma-derived growth factor in hepatocellular carcinoma.
    Hu TH, Huang CC, Liu LF, Lin PR, Liu SY, Chang HW, Changchien CS, Lee CM, Chuang JH, Tai MH.
    Cancer; 2003 Oct 01; 98(7):1444-56. PubMed ID: 14508832
    [Abstract] [Full Text] [Related]

  • 15. Serum tissue polypeptide specific antigen as a noninvasive prognostic indicator for early recurrence of hepatocellular carcinoma after curative resection.
    Yao WJ, Wang ST, Chow NH, Chang TT, Lin PW, Tu DG.
    Cancer; 2002 Jul 01; 95(1):112-8. PubMed ID: 12115324
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Osteopontin, a single marker for predicting the prognosis of patients with tumor-node-metastasis stage I hepatocellular carcinoma after surgical resection.
    Chen RX, Xia YH, Cui JF, Xue TC, Ye SL.
    J Gastroenterol Hepatol; 2010 Aug 01; 25(8):1435-42. PubMed ID: 20659235
    [Abstract] [Full Text] [Related]

  • 18. [Expression of proliferating cell nucleus antigen and nm23 protein and their relation with metastasis in hepatocellular carcinoma].
    Luo HY, Wang HC, Feng DY.
    Hunan Yi Ke Da Xue Xue Bao; 2003 Feb 28; 28(1):17-9. PubMed ID: 12934386
    [Abstract] [Full Text] [Related]

  • 19. Long term prognosis after hepatectomy for hepatocellular carcinoma: a survival analysis of 204 consecutive patients.
    Lau H, Fan ST, Ng IO, Wong J.
    Cancer; 1998 Dec 01; 83(11):2302-11. PubMed ID: 9840529
    [Abstract] [Full Text] [Related]

  • 20. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.
    Shah SA, Cleary SP, Wei AC, Yang I, Taylor BR, Hemming AW, Langer B, Grant DR, Greig PD, Gallinger S.
    Surgery; 2007 Mar 01; 141(3):330-9. PubMed ID: 17349844
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.